Skip to main content
. 2013 Sep 25;30(6):2617–2624. doi: 10.3892/or.2013.2753

Figure 2.

Figure 2

Figure 2

(A) h-TERT and (B) h-TERC relative mRNA expression in the BALF samples from the control subjects and patients with IPF and NSCLC. *p<0.05 vs. IPF. NSCLC, non-small cell lung cancer; IFP, idiopathic pulmonary fibrosis; BALF, bronchoalveolar lavage fluid.